Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Respiratory Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
FibroGen
Abbott
Pfizer
Dainippon Sumitomo
Horizon Pharma
Afferent Pharmaceuticals
Amgen
By Type:
Asthma
Chronic Obstructive Pulmonary Disease
Cystic Fibrosis
Idiopathic Pulmonary Fibrosis
By Application:
Hospitals
Others
Ambulatory Care
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Respiratory Drugs Market Overview 2018-2029
-
1.1 China Respiratory Drugs Industry Development Overview
-
1.2 China Respiratory Drugs Industry Development History
-
1.3 China Respiratory Drugs Industry Market Size (2018-2029)
-
1.4 China Respiratory Drugs Market Analysis by Type from Production Side
-
1.4.1 China Respiratory Drugs Production Volume, Production Value and Growth Rate of Asthma (2018-2029)
-
1.4.2 China Respiratory Drugs Production Volume, Production Value and Growth Rate of Chronic Obstructive Pulmonary Disease (2018-2029)
-
1.4.3 China Respiratory Drugs Production Volume, Production Value and Growth Rate of Cystic Fibrosis (2018-2029)
-
1.4.4 China Respiratory Drugs Production Volume, Production Value and Growth Rate of Idiopathic Pulmonary Fibrosis (2018-2029)
-
1.5 China Respiratory Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Respiratory Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.5.2 China Respiratory Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.3 China Respiratory Drugs Sales Volume, Sales Value and Growth Rate of Ambulatory Care (2018-2029)
-
1.6 China Respiratory Drugs Market Analysis by Region
-
1.6.1 North China Respiratory Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Respiratory Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Respiratory Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Respiratory Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Respiratory Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Respiratory Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Respiratory Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Respiratory Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Respiratory Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Respiratory Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Respiratory Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Respiratory Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Respiratory Drugs Industry Development
Chapter 3 Respiratory DrugsIndustry Chain Analysis
-
3.1 Respiratory Drugs Industry Chain
-
3.2 Respiratory Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Respiratory Drugs Market
-
3.3 Respiratory Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Respiratory Drugs Market
Chapter 4 China Respiratory Drugs Market, by Type
-
4.1 China Respiratory Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Respiratory Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Respiratory Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Respiratory Drugs Production Volume and Growth Rate of Asthma
-
4.5.2 China Respiratory Drugs Production Volume and Growth Rate of Chronic Obstructive Pulmonary Disease
-
4.5.3 China Respiratory Drugs Production Volume and Growth Rate of Cystic Fibrosis
-
4.5.4 China Respiratory Drugs Production Volume and Growth Rate of Idiopathic Pulmonary Fibrosis
Chapter 5 China Respiratory Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Respiratory Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Respiratory Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Respiratory Drugs Market Size and Growth Rate of Hospitals
-
5.5.2 China Respiratory Drugs Market Size and Growth Rate of Others
-
5.5.3 China Respiratory Drugs Market Size and Growth Rate of Ambulatory Care
Chapter 6 China Respiratory Drugs Market, by Region
-
6.1 China Respiratory Drugs Production Volume and Production Value, by Region
-
6.2 China Respiratory Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Respiratory Drugs Market Analysis
-
7.1 North China Respiratory Drugs Market, by Type
-
7.2 North China Respiratory Drugs Market, by Application
Chapter 8 Central China Respiratory Drugs Market Analysis
-
8.1 Central China Respiratory Drugs Market, by Type
-
8.2 Central China Respiratory Drugs Market, by Application
Chapter 9 South China Respiratory Drugs Market Analysis
-
9.1 South China Respiratory Drugs Market, by Type
-
9.2 South China Respiratory Drugs Market, by Application
Chapter 10 East China Respiratory Drugs Market Analysis
-
10.1 East China Respiratory Drugs Market, by Type
-
10.2 East China Respiratory Drugs Market, by Application
Chapter 11 Northeast China Respiratory Drugs Market Analysis
-
11.1 Northeast China Respiratory Drugs Market, by Type
-
11.2 Northeast China Respiratory Drugs Market, by Application
Chapter 12 Southwest China Respiratory Drugs Market Analysis
-
12.1 Southwest China Respiratory Drugs Market, by Type
-
12.2 Southwest China Respiratory Drugs Market, by Application
Chapter 13 Northwest China Respiratory Drugs Market Analysis
-
13.1 Northwest China Respiratory Drugs Market, by Type
-
13.2 Northwest China Respiratory Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 FibroGen
-
14.1.1 FibroGen Company Profile
-
14.1.2 FibroGen Respiratory Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Abbott
-
14.2.1 Abbott Company Profile
-
14.2.2 Abbott Respiratory Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Pfizer
-
14.3.1 Pfizer Company Profile
-
14.3.2 Pfizer Respiratory Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Dainippon Sumitomo
-
14.4.1 Dainippon Sumitomo Company Profile
-
14.4.2 Dainippon Sumitomo Respiratory Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Horizon Pharma
-
14.5.1 Horizon Pharma Company Profile
-
14.5.2 Horizon Pharma Respiratory Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Afferent Pharmaceuticals
-
14.6.1 Afferent Pharmaceuticals Company Profile
-
14.6.2 Afferent Pharmaceuticals Respiratory Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Amgen
-
14.7.1 Amgen Company Profile
-
14.7.2 Amgen Respiratory Drugs Market Performance
-
14.7.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Respiratory Drugs Industry Research Conclusions
-
15.2 Respiratory Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Respiratory Drugs Industry Market Size (2018-2029)
-
Figure China Respiratory Drugs Production Volume, Production Value and Growth Rate of Asthma (2018-2029)
-
Figure China Respiratory Drugs Production Volume, Production Value and Growth Rate of Chronic Obstructive Pulmonary Disease (2018-2029)
-
Figure China Respiratory Drugs Production Volume, Production Value and Growth Rate of Cystic Fibrosis (2018-2029)
-
Figure China Respiratory Drugs Production Volume, Production Value and Growth Rate of Idiopathic Pulmonary Fibrosis (2018-2029)
-
Figure China Respiratory Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure China Respiratory Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Respiratory Drugs Sales Volume, Sales Value and Growth Rate of Ambulatory Care (2018-2029)
-
Figure North China Respiratory Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Respiratory Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Respiratory Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Respiratory Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Respiratory Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Respiratory Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Respiratory Drugs Market Size and Growth Rate from 2018-2029
-
Figure Respiratory Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Respiratory Drugs Market Share by Type in 2018
-
Figure China Respiratory Drugs Market Share by Type in 2023
-
Figure China Respiratory Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Respiratory Drugs Production Volume and Growth Rate of Asthma (2018-2023)
-
Figure China Respiratory Drugs Production Volume and Growth Rate of Chronic Obstructive Pulmonary Disease (2018-2023)
-
Figure China Respiratory Drugs Production Volume and Growth Rate of Cystic Fibrosis (2018-2023)
-
Figure China Respiratory Drugs Production Volume and Growth Rate of Idiopathic Pulmonary Fibrosis (2018-2023)
-
Figure China Respiratory Drugs Market Share by Application in 2018
-
Figure China Respiratory Drugs Market Share by Application in 2023
-
Figure China Respiratory Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Respiratory Drugs Market Size and Growth Rate of Hospitals (2018-2023)
-
Figure China Respiratory Drugs Market Size and Growth Rate of Others (2018-2023)
-
Figure China Respiratory Drugs Market Size and Growth Rate of Ambulatory Care (2018-2023)
-
Table China Respiratory Drugs Production Volume by Region (2018-2023)
-
Table China Respiratory Drugs Production Volume Share by Region (2018-2023)
-
Figure China Respiratory Drugs Production Volume Share by Region (2018-2023)
-
Table China Respiratory Drugs Production Value by Region (2018-2023)
-
Table China Respiratory Drugs Production Value Share by Region (2018-2023)
-
Figure China Respiratory Drugs Production Value Share by Region (2018-2023)
-
Table China Respiratory Drugs Sales Volume by Region (2018-2023)
-
Table China Respiratory Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Respiratory Drugs Sales Volume Share by Region (2018-2023)
-
Table China Respiratory Drugs Sales Value by Region (2018-2023)
-
Table China Respiratory Drugs Sales Value Share by Region (2018-2023)
-
Figure China Respiratory Drugs Sales Value Share by Region (2018-2023)
-
Table North China Respiratory Drugs Production Volume by Type (2018-2023)
-
Table North China Respiratory Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Respiratory Drugs Production Volume Share by Type (2018-2023)
-
Table North China Respiratory Drugs Sales Volume by Application (2018-2023)
-
Table North China Respiratory Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Respiratory Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Respiratory Drugs Production Volume by Type (2018-2023)
-
Table Central China Respiratory Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Respiratory Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Respiratory Drugs Sales Volume by Application (2018-2023)
-
Table Central China Respiratory Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Respiratory Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Respiratory Drugs Production Volume by Type (2018-2023)
-
Table South China Respiratory Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Respiratory Drugs Production Volume Share by Type (2018-2023)
-
Table South China Respiratory Drugs Sales Volume by Application (2018-2023)
-
Table South China Respiratory Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Respiratory Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Respiratory Drugs Production Volume by Type (2018-2023)
-
Table East China Respiratory Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Respiratory Drugs Production Volume Share by Type (2018-2023)
-
Table East China Respiratory Drugs Sales Volume by Application (2018-2023)
-
Table East China Respiratory Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Respiratory Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Respiratory Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Respiratory Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Respiratory Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Respiratory Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Respiratory Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Respiratory Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Respiratory Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Respiratory Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Respiratory Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Respiratory Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Respiratory Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Respiratory Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Respiratory Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Respiratory Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Respiratory Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Respiratory Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Respiratory Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Respiratory Drugs Sales Volume Share by Application (2018-2023)
-
Table FibroGen Company Profile
-
Table FibroGen Respiratory Drugs Revenue, Price and Gross (2018-2023)
-
Table Abbott Company Profile
-
Table Abbott Respiratory Drugs Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Respiratory Drugs Revenue, Price and Gross (2018-2023)
-
Table Dainippon Sumitomo Company Profile
-
Table Dainippon Sumitomo Respiratory Drugs Revenue, Price and Gross (2018-2023)
-
Table Horizon Pharma Company Profile
-
Table Horizon Pharma Respiratory Drugs Revenue, Price and Gross (2018-2023)
-
Table Afferent Pharmaceuticals Company Profile
-
Table Afferent Pharmaceuticals Respiratory Drugs Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Respiratory Drugs Revenue, Price and Gross (2018-2023)
-
